Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

9
Number of overlapping holdings
8.1%
% of IXJ's 114 holdings also in XPH
24.3%
% of XPH's 40 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in IXJ |
Weight in XPH |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 6.5% | 5.6% | 5.6% | |
JOHNSON & JOHNSON | 5.6% | 4.0% | 4.0% | |
MERCK & CO. INC. | 3.9% | 4.2% | 3.9% | |
PFIZER INC | 2.8% | 3.8% | 2.8% | |
BRISTOL-MYERS SQUIBB CO | 1.8% | 3.9% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to XPH
UNITEDHEALTH GROUP INC | 6.5% | |
ABBVIE INC | 3.8% | |
NOVARTIS AG | 3.5% | |
ASTRAZENECA PLC | 3.0% | |
ROCHE HOLDING LTD | 2.9% | |
THERMO FISHER SCIENTIFIC INC | 2.8% | |
ABBOTT LABORATORIES | 2.5% | |
DANAHER CORP | 2.4% | |
AMGEN INC | 2.0% | |
SANOFI-AVENTIS | 1.8% |
IXJ Underweight Relative to XPH
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% | |
ELANCO ANIMAL HEALTH, INC. | -5.7% | |
CATALENT INC | -5.3% | |
JAZZ PHARMACEUTICALS PLC | -4.5% | |
AXSOME THERAPEUTICS, INC. | -4.4% | |
VIATRIS, INC. | -4.3% | |
ORGANON & CO. | -3.8% | |
PERRIGO CO | -3.7% | |
ROYALTY PHARMA PLC CLASS A | -3.7% | |
INTRA-CELLULAR THERAPIES INC | -3.6% |